Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

An Interaction with PARP-1 and Inhibition of Parylation Contribute to Attenuation of DNA Damage Signaling by the Adenovirus E4orf4 Protein.

Nebenzahl-Sharon K, Sharf R, Amer J, Shalata H, Khoury-Haddad H, Sohn SY, Ayoub N, Hearing P, Kleinberger T.

J Virol. 2019 Sep 12;93(19). pii: e02253-18. doi: 10.1128/JVI.02253-18. Print 2019 Oct 1.

PMID:
31315986
2.

Selective elimination of cancer cells by the adenovirus E4orf4 protein in a Drosophila cancer model: a new paradigm for cancer therapy.

Rosen H, Sharf R, Pechkovsky A, Salzberg A, Kleinberger T.

Cell Death Dis. 2019 Jun 11;10(6):455. doi: 10.1038/s41419-019-1680-4.

3.

Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK.

Nebenzahl-Sharon K, Shalata H, Sharf R, Amer J, Khoury-Haddad H, Sohn SY, Ayoub N, Hearing P, Kleinberger T.

J Virol. 2019 May 1;93(10). pii: e01365-18. doi: 10.1128/JVI.01365-18. Print 2019 May 15.

4.

The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.

Brestovitsky A, Nebenzahl-Sharon K, Kechker P, Sharf R, Kleinberger T.

PLoS Pathog. 2016 Feb 11;12(2):e1005420. doi: 10.1371/journal.ppat.1005420. eCollection 2016 Feb.

5.

Is mindfulness Buddhist? (and why it matters).

Sharf RH.

Transcult Psychiatry. 2015 Aug;52(4):470-84. doi: 10.1177/1363461514557561. Epub 2014 Oct 31.

PMID:
25361692
6.

NTPDASE4 gene products cooperate with the adenovirus E4orf4 protein through PP2A-dependent and -independent mechanisms and contribute to induction of cell death.

Avital-Shacham M, Sharf R, Kleinberger T.

J Virol. 2014 Jun;88(11):6318-28. doi: 10.1128/JVI.00381-14. Epub 2014 Mar 26.

7.

Structure- and modeling-based identification of the adenovirus E4orf4 binding site in the protein phosphatase 2A B55α subunit.

Horowitz B, Sharf R, Avital-Shacham M, Pechkovsky A, Kleinberger T.

J Biol Chem. 2013 May 10;288(19):13718-27. doi: 10.1074/jbc.M112.343756. Epub 2013 Mar 25.

8.
9.

The adenovirus E4orf4 protein targets PP2A to the ACF chromatin-remodeling factor and induces cell death through regulation of SNF2h-containing complexes.

Brestovitsky A, Sharf R, Mittelman K, Kleinberger T.

Nucleic Acids Res. 2011 Aug;39(15):6414-27. doi: 10.1093/nar/gkr231. Epub 2011 May 5.

10.

Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone.

Sears RM, Liu RJ, Narayanan NS, Sharf R, Yeckel MF, Laubach M, Aghajanian GK, DiLeone RJ.

J Neurosci. 2010 Jun 16;30(24):8263-73. doi: 10.1523/JNEUROSCI.5858-09.2010.

11.

Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.

Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ.

Biol Psychiatry. 2010 Apr 15;67(8):753-60. doi: 10.1016/j.biopsych.2009.12.035. Epub 2010 Feb 26.

12.

Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.

Sharf R, Guarnieri DJ, Taylor JR, DiLeone RJ.

Brain Res. 2010 Mar 4;1317:24-32. doi: 10.1016/j.brainres.2009.12.035. Epub 2009 Dec 23.

13.

Role of orexin/hypocretin in dependence and addiction.

Sharf R, Sarhan M, Dileone RJ.

Brain Res. 2010 Feb 16;1314:130-8. doi: 10.1016/j.brainres.2009.08.028. Epub 2009 Aug 20. Review.

14.

Adenovirus E4orf4 protein downregulates MYC expression through interaction with the PP2A-B55 subunit.

Ben-Israel H, Sharf R, Rechavi G, Kleinberger T.

J Virol. 2008 Oct;82(19):9381-8. doi: 10.1128/JVI.00791-08. Epub 2008 Jul 23.

15.

Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.

Sharf R, Sarhan M, Dileone RJ.

Biol Psychiatry. 2008 Aug 1;64(3):175-83. doi: 10.1016/j.biopsych.2008.03.006. Epub 2008 Apr 18.

16.

Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats.

Sharf R, McKelvey J, Ranaldi R.

Psychopharmacology (Berl). 2006 May;186(1):113-21. Epub 2006 Mar 9.

PMID:
16525855
17.

Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats.

Sharf R, Ranaldi R.

Psychopharmacology (Berl). 2006 Jan;184(1):87-94. Epub 2005 Nov 24.

PMID:
16307293
19.

Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.

Quinlan MG, Sharf R, Lee DY, Wise RA, Ranaldi R.

Psychopharmacology (Berl). 2004 Aug;175(1):53-9. Epub 2004 Feb 7.

PMID:
14767633
20.

Using the Ras Recruitment System to identify PP2A-B55-interacting proteins.

Barr HM, Sharf R, Kleinberger T.

Methods Enzymol. 2003;366:175-87.

PMID:
14674249
21.

A bacteriophage reagent for Salmonella: molecular studies on Felix 01.

Kuhn J, Suissa M, Chiswell D, Azriel A, Berman B, Shahar D, Reznick S, Sharf R, Wyse J, Bar-On T, Cohen I, Giles R, Weiser I, Lubinsky-Mink S, Ulitzur S.

Int J Food Microbiol. 2002 Apr 5;74(3):217-27. Review.

PMID:
11981972
23.

Selection of apoptosis-deficient adenovirus E4orf4 mutants in Saccharomyces cerevisiae.

Afifi R, Sharf R, Shtrichman R, Kleinberger T.

J Virol. 2001 May;75(9):4444-7. Erratum in: J Virol 2001 Jun;75(12):5719.

25.
26.

Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A.

Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10080-5.

27.

Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells.

Mandel H, Sharf R, Berant M, Wanders RJ, Vreken P, Aviram M.

Biochem Biophys Res Commun. 1998 Sep 18;250(2):369-73.

PMID:
9753636
28.

Functional domains of interferon regulatory factor I (IRF-1).

Schaper F, Kirchhoff S, Posern G, Köster M, Oumard A, Sharf R, Levi BZ, Hauser H.

Biochem J. 1998 Oct 1;335 ( Pt 1):147-57.

29.

Dorsotonals/homothorax, the Drosophila homologue of meis1, interacts with extradenticle in patterning of the embryonic PNS.

Kurant E, Pai CY, Sharf R, Halachmi N, Sun YH, Salzberg A.

Development. 1998 Mar;125(6):1037-48.

30.

Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA.

Sharf R, Meraro D, Azriel A, Thornton AM, Ozato K, Petricoin EF, Larner AC, Schaper F, Hauser H, Levi BZ.

J Biol Chem. 1997 Apr 11;272(15):9785-92.

31.

A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.

Thornton AM, Ogryzko VV, Dent A, Sharf R, Levi BZ, Kanno Y, Staudt LM, Howard BH, Ozato K.

J Immunol. 1996 Dec 1;157(11):5145-54. Erratum in: J Immunol 1999 Mar 1;162(5):3103.

PMID:
8943426
32.

Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors.

Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, Levi BZ.

J Biol Chem. 1995 Jun 2;270(22):13063-9.

33.

Seizure from hyponatremia in infants. Early recognition and treatment.

Sharf RE.

Arch Fam Med. 1993 Jun;2(6):647-52.

PMID:
8118585
34.

Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.

Weisz A, Marx P, Sharf R, Appella E, Driggers PH, Ozato K, Levi BZ.

J Biol Chem. 1992 Dec 15;267(35):25589-96.

35.
36.

Template-selective stimulation of diverse DNA polymerases by the murine DNA-binding protein factor D.

Fry M, Weisman-Shomer P, Lapidot J, Sharf R.

J Biol Chem. 1987 Jun 25;262(18):8861-7.

37.

The DNA sequence specificity of stimulation of DNA polymerases by factor D.

Fry M, Sharf R, Weisman-Shomer P, Evers PC, Loeb LA.

J Biol Chem. 1987 Jun 25;262(18):8868-74.

39.

[Arthropathies in enteropathies: clinico-statistical observations on ulcerative colitis].

Ferri S, Sharf R, Azzaroli R, Stefanini A, Di Gioia S, Lia C.

Reumatismo. 1977 Apr-Jun;28(2):116-8. Italian. No abstract available.

PMID:
866806
40.

A new game people play. "Self control".

Sharf R.

J Am Soc Prev Dent. 1972 Jan-Feb;2(1):21-1 passim. No abstract available.

PMID:
4503180
41.

[Hazards and complications arising during blood transfusions].

Rudovskiĭ V, Sharf R, Shir Iu.

Probl Gematol Pereliv Krovi. 1969 Jan;14(1):11-3. Russian. No abstract available.

PMID:
5800781

Supplemental Content

Support Center